“Aktiia’s bracelet and algorithms have now been validated in clinical trials against arterial lines (the gold standard for clinical reference) and in ambulatory settings. Never before has it been possible to measure blood pressure profiles, at any time, over long periods. This valuable and unique dataset will allow for broader insights into the diagnosis and treatment of hypertension, the largest epidemic of humankind.”
/ News
EU Startups — Swiss medtech Aktiia raises €5.6 million to bring its hypertension monitor bracelet to market
Last reviewed:
24 Mar 2020,
Author:
Read next
Traditional blood pressure cuff vs. Aktiia
Cuff
Aktiia
Meets ISO81060-2 Standard
Day-Time Blood Pressure
Average 70+
measurements a week
Night-Time Blood Pressure
Automatic Measurements
About the Author
Mattia Bertschi is a Swiss entrepreneur, biomedical engineer, Co-Founder and Chief Operating Officer at Aktiia.
Bertschi obtained his Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Lausanne in 2005. His doctoral research focused on biomedical signal processing and biophysical modelling, specifically studying the electrical and mechanical activity of the intestine.
Stay updated
Join our mailing list for the latest developments.